1.
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
by Lamarre, Daniel
Nature, 2003, Vol.426 (6963), p.186-189
2.
Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors
by Adibekian, Alexander
Nature chemical biology, 2011, Vol.7 (7), p.469-478
3.
Molecular characterization of serine protease inhibitor isoform 3, SmSPI, from Schistosoma mansoni
by Pakchotanon, Pattarakul
Parasitology research (1987), 2016, Vol.115 (8), p.2981-2994
4.
Expression and function assessment of two serpin-type serine protease inhibitors from Haemaphysalis doenitzi
by Du, Wenjing
Research in veterinary science, 2020, Vol.132, p.1-9
5.
Cysteine protease inhibitor of Schistosoma japonicum - A parasite-derived negative immunoregulatory factor
by Chen, Lin
Parasitology research (1987), 2017, Vol.116 (3), p.901-908
6.
7.
Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine
by Singh, Juswinder
Nature Chemical Biology, 2011, Vol.7 (1), p.22-24
8.
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
by Welsch, Christoph
Gut, 2012, Vol.61 (Suppl 1), p.i36-i46
9.
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients
by Ramachandran, P.
Alimentary pharmacology & therapeutics, 2012, Vol.35 (6), p.647-662
10.
SPARTA clinical trial design: Exploring the efficacy and safety of two dose regimens of alpha1 -proteinase inhibitor augmentation therapy in alpha1 -antitrypsin deficiency
by Sorrells, Susan
Respiratory medicine, 2015, Vol.109 (4), p.490-499
11.
A barley cysteine-proteinase inhibitor reduces the performance of two aphid species in artificial diets and transgenic Arabidopsis plants
by Carrillo, Laura
Transgenic research, 2010, Vol.20 (2), p.305-319
12.
Survivin is released from cancer cells via exosomes
by Khan, Salma
Apoptosis (London), 2010, Vol.16 (1), p.1-12
13.
Lipid‐lowering therapy with PCSK9‐inhibitors in the real‐world setting: Two‐year experience of a regional lipid clinic
by Zafrir, Barak
Cardiovascular therapeutics, 2018, Vol.36 (5), p.e12439-n/a
14.
Crystal structure of tarocystatin-papain complex: implications for the inhibition property of group-2 phytocystatins
by Chu, Ming-Hung
Planta, 2011, Vol.234 (2), p.243-254
15.
The Role of Computed Tomography for the Evaluation of Lung Disease in Alpha-1 Antitrypsin Deficiency
by Campos, Michael A
Chest, 2018, Vol.153 (5), p.1240-1248
16.
Activity-based probes that target diverse cysteine protease families
by Bogyo, Matthew
Nature chemical biology, 2005, Vol.1 (1), p.33-38
17.
Viral Subversion of Apoptotic Enzymes : Escape from Death Row
by BEST, Sonja M
Annual review of microbiology, 2008, Vol.62 (1), p.171-192
18.
Properties of a Non-canonical Complex Formed Between a Tepary Bean (Phaseolus acutifolius) Protease Inhibitor and α-Chymotrypsin
by Pliego-Arreaga, Raquel
The Protein Journal, 2019, Vol.38 (4), p.435-446
19.
Effects of the early administration of sivelestat sodium on bronchopulmonary dysplasia in infants: A retrospective cohort study
by Ogawa, Ryo
Early human development, 2017, Vol.115, p.71-76
20.
SERPINE2, a Serine Protease Inhibitor Extensively Expressed in Adult Male Mouse Reproductive Tissues, May Serve as a Murine Sperm Decapacitation Factor
by LU, Chung-Hao
Biology of reproduction, 2011, Vol.84 (3), p.514-525
